Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine.
- DOI
- 10.1038/s41417-023-00658-3
- Published
- 2023 Nov
- Container
- Cancer gene therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41417-023-00658-3,
title = {Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine.},
author = {Quixabeira DCA and Jirovec E and Pakola S and Havunen R and Basnet S and Santos JM and Kudling TV and Clubb JHA and Haybout L and Arias V and Grönberg-Vähä-Koskela S and Cervera-Carrascon V and Pasanen A and Anttila M and Tapper J and Kanerva A and Hemminki A},
year = {2023},
journal = {Cancer gene therapy},
doi = {10.1038/s41417-023-00658-3},
url = {https://doi.org/10.1038/s41417-023-00658-3}
}RIS
TY - JOUR TI - Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine. AU - Quixabeira DCA AU - Jirovec E AU - Pakola S AU - Havunen R AU - Basnet S AU - Santos JM AU - Kudling TV AU - Clubb JHA AU - Haybout L AU - Arias V AU - Grönberg-Vähä-Koskela S AU - Cervera-Carrascon V AU - Pasanen A AU - Anttila M AU - Tapper J AU - Kanerva A AU - Hemminki A PY - 2023 JO - Cancer gene therapy DO - 10.1038/s41417-023-00658-3 UR - https://doi.org/10.1038/s41417-023-00658-3 ER -
APA
DCA, Q., E, J., S, P., R, H., S, B., JM, S., TV, K., JHA, C., L, H., V, A., S, G., V, C., A, P., M, A., J, T., A, K., & A, H. (2023). Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine.. Cancer gene therapy. https://doi.org/10.1038/s41417-023-00658-3
Source records
- pubmed · retrieved 2026-09-27T00:45:08.739Z
- europe-pmc · retrieved 2026-09-27T00:45:08.750Z